ES-2（人卵巢透明細(xì)胞癌細(xì)胞）

 ES-2（人卵巢透明細(xì)胞癌細(xì)胞）  
產(chǎn)品品牌：ATCC
價(jià)格：詢(xún)價(jià)
我公司擁有國(guó)內(nèi)的細(xì)胞服務(wù)技術(shù)、先進(jìn)的儀器設(shè)備和專(zhuān)業(yè)的ELISA檢測(cè)試劑盒， 生物素標(biāo)記、熒光素標(biāo)記、酶標(biāo)記等，廣泛用于多種分析研究與技術(shù)測(cè)定。

產(chǎn)品說(shuō)明：
The ES-2 cell line was established from a surgical tumor specimen taken from a 47 year old black woman.
The tumor was described as a poorly differentiated ovarian clear cell carcinoma.
Initially, the cells were grown in soft agar.
The cells exhibit low to moderate resistance to a number of chemotherapeutic agents including doxorubicin, cisplatin, carmustine, etoposide and cyanomorpholinodoxorubicin （MRA-CN）.
ES-2 cells express low levels of P glycoprotein.

相關(guān)產(chǎn)品：
ES-2（人卵巢透明細(xì)胞癌細(xì)胞） 
LoVo（人結(jié)腸癌細(xì)胞） 
HT-29（人結(jié)腸癌細(xì)胞） 
TE 115.T（人軟組織纖維瘤細(xì)胞） 
Cates-1B（人睪丸淋巴胚胎性癌細(xì)胞） 
SNU-398（人肝癌細(xì)胞） 
Hep 3B2.1-7 [Hep 3B; Hep-3B; Hep3B]（人肝癌細(xì)胞）